Literature DB >> 8945583

Intimin from enteropathogenic Escherichia coli restores murine virulence to a Citrobacter rodentium eaeA mutant: induction of an immunoglobulin A response to intimin and EspB.

G Frankel1, A D Phillips, M Novakova, H Field, D C Candy, D B Schauer, G Douce, G Dougan.   

Abstract

The formation of attaching and effacing (A/E) lesions is central to the pathogenesis of enteropathogenic Escherichia coli (EPEC)-mediated disease in humans and Citrobacter rodentium (formerly C. freundii biotype 4280)-mediated transmissible colonic hyperplasia in mice. Closely related outer membrane proteins, known as intimins, are required for formation of the A/E lesion by both EPEC (Int(EPEC)) and C. rodentium (Int(CR)). A secreted protein, EspB (formally EaeB), is also necessary for A/E-lesion formation. Here we report that expression of a cloned Int(EPEC), encoded by plasmid pCVD438, restores murine virulence to an intimin-deficient mutant of C. rodentium DBS255. Replacement of Cys937 with Ala abolished the ability of the cloned EPEC intimin to complement the deletion mutation in DBS255. Ultrastructural examination of tissues from wild-type C. rodentium and DBS255(pCVD438)-infected mice revealed multiple A/E lesion on infected cells and loss of contact between enterocytes and basement membrane. Histological investigation showed that although both wild-type C. rodentium and DBS255(pCVD438) colonized the descending colon and induced colonic hyperplasia in orally infected 21-day-old mice, the latter strain adhered to epithelial cells located deeper within crypts. Nonetheless, infection with the wild-type strain was consistently more virulent, as indicated by a higher mortality rate. All the surviving mice, challenged with either wild-type C. rodentium or DBS255(pCVD438), developed a mucosal immunoglobulin A response to intimin and EspB. These results show that C. rodentium infection provides a relevant, simple, and economic model to investigate the role of EPEC proteins in the formation of A/E lesions in vivo and in intestinal disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8945583      PMCID: PMC174525          DOI: 10.1128/iai.64.12.5315-5325.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  The eae gene of enteropathogenic Escherichia coli encodes a 94-kilodalton membrane protein, the expression of which is influenced by the EAF plasmid.

Authors:  A E Jerse; J B Kaper
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

2.  Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction.

Authors:  K B Mullis; F A Faloona
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

3.  Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian Theory of the origin of the four epithelial cell types.

Authors:  H Cheng; C P Leblond
Journal:  Am J Anat       Date:  1974-12

4.  Pathogenesis of escherichia coli gastroenteritis in man--another mechanism.

Authors:  M H Ulshen; J L Rollo
Journal:  N Engl J Med       Date:  1980-01-10       Impact factor: 91.245

5.  A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells.

Authors:  A E Jerse; J Yu; B D Tall; J B Kaper
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

6.  The diarrheal response of humans to some classic serotypes of enteropathogenic Escherichia coli is dependent on a plasmid encoding an enteroadhesiveness factor.

Authors:  M M Levine; J P Nataro; H Karch; M M Baldini; J B Kaper; R E Black; M L Clements; A D O'Brien
Journal:  J Infect Dis       Date:  1985-09       Impact factor: 5.226

7.  Genetic and biochemical characterization of Citrobacter rodentium sp. nov.

Authors:  D B Schauer; B A Zabel; I F Pedraza; C M O'Hara; A G Steigerwalt; D J Brenner
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

8.  Transmissible murine colonic hyperplasia.

Authors:  S W Barthold; G L Coleman; R O Jacoby; E M Livestone; A M Jonas
Journal:  Vet Pathol       Date:  1978-03       Impact factor: 2.221

9.  Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive.

Authors:  M M Levine; E J Bergquist; D R Nalin; D H Waterman; R B Hornick; C R Young; S Sotman
Journal:  Lancet       Date:  1978-05-27       Impact factor: 79.321

Review 10.  Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent.

Authors:  M M Levine
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226

View more
  50 in total

Review 1.  The immune responses to bacterial antigens encountered in vivo at mucosal surfaces.

Authors:  G Dougan; M Ghaem-Maghami; D Pickard; G Frankel; G Douce; S Clare; S Dunstan; C Simmons
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-05-29       Impact factor: 6.237

2.  Atypical Enteropathogenic Escherichia coli: from Kittens to Humans and Beyond!

Authors:  Shantanu Bhatt
Journal:  Infect Immun       Date:  2021-02-16       Impact factor: 3.441

3.  Effect of probiotics Lactobacillus acidophilus on Citrobacter rodentium colitis: the role of dendritic cells.

Authors:  Chien-Chang Chen; Cheng-Hsun Chiu; Tzou-Yien Lin; Hai Ning Shi; W Allan Walker
Journal:  Pediatr Res       Date:  2009-02       Impact factor: 3.756

4.  Gamma interferon produced by antigen-specific CD4+ T cells regulates the mucosal immune responses to Citrobacter rodentium infection.

Authors:  Hideyuki Shiomi; Atsuhiro Masuda; Shin Nishiumi; Masayuki Nishida; Tetsuya Takagawa; Yuuki Shiomi; Hiromu Kutsumi; Richard S Blumberg; Takeshi Azuma; Masaru Yoshida
Journal:  Infect Immun       Date:  2010-03-29       Impact factor: 3.441

5.  Role of periplasmic chaperones and BamA (YaeT/Omp85) in folding and secretion of intimin from enteropathogenic Escherichia coli strains.

Authors:  Gustavo Bodelón; Elvira Marín; Luis Angel Fernández
Journal:  J Bacteriol       Date:  2009-06-12       Impact factor: 3.490

6.  Effect of prior experimental human enteropathogenic Escherichia coli infection on illness following homologous and heterologous rechallenge.

Authors:  M S Donnenberg; C O Tacket; G Losonsky; G Frankel; J P Nataro; G Dougan; M M Levine
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

Review 7.  The microbiome and regulation of mucosal immunity.

Authors:  Andrew J McDermott; Gary B Huffnagle
Journal:  Immunology       Date:  2014-05       Impact factor: 7.397

8.  IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesion-forming enteric bacterial pathogens.

Authors:  Sara M Dann; Martina E Spehlmann; Dustin C Hammond; Mitsutoshi Iimura; Koji Hase; Lillian J Choi; Elaine Hanson; Lars Eckmann
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

9.  Identification of immunodominant regions within the C-terminal cell binding domain of intimin alpha and intimin beta from enteropathogenic Escherichia coli.

Authors:  J Adu-Bobie; L R Trabulsi; M M Carneiro-Sampaio; G Dougan; G Frankel
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

Review 10.  In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections.

Authors:  Robyn J Law; Lihi Gur-Arie; Ilan Rosenshine; B Brett Finlay
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.